We’re live at #ACC25! Stop by Booth #25031 to learn more about our work in advancing #HeartHealth or join us for lunch at an ACC session of interest in the Industry Expert Theater in the Expo Hall, Theater 1. We’ll be exploring AAV #GeneTherapy for #CardiovascularHealth and sharing the latest updates on our GenePHIT Phase 2 investigational clinical trial.?? ? Check out the ACC.25 agenda and save the date for our Industry Expert Theater event on 3/31: https://bit.ly/41masXp? ? American College of Cardiology? #GeneTherapy #HeartFailure #CHF #ClinicalTrials
关于我们
AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10?, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: ? Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. ? Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. ? Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. ? Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. ? Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.
- 网站
-
https://www.askbio.com
AskBio Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Research Triangle Park,North Carolina
- 类型
- 私人持股
- 领域
- AAV、Adeno-Associated Virus、Gene Therapy、Rare Disease、AAV Manufacturing、Molecular Medicine、Nucleic Acid、Epigenome和Doggybone DNA
地点
AskBio Inc.员工
-
Gustavo Pesquin
-
Doug Schantz
Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc. (AskBio)
-
Kira Mour?o MBCS
Principal Machine Learning Scientist at Asklepios BioPharmaceutical, Inc. - (AskBio)
-
Kara Witcoff
Patient Advocacy & External Engagement / Public Affairs / Strategic Alliances / Business Development / Global Relations
动态
-
#MarchMadness took over last Friday’s lunch at #AskBio’s headquarters and Discovery 1 offices in the Research Triangle Park. It was all about team spirit, connection, and some good-natured rivalries. Events like these reflect our culture of cultivating collaboration, and whether in the lab or over lunch, we believe strong teams fuel big breakthroughs. Kudos to our Facilities colleagues for coordinating this watch party, which brought employees together to connect and watch the action.?It’s always a little extra exciting watching this tournament in North Carolina, being surrounded by some of the nation’s top Men’s and Women’s college basketball programs, including those from several schools we recently visited to join their career fairs. University of North Carolina at Chapel Hill, Duke University, North Carolina State University Lawrence Shedrick, Lauren Nufer, Patrick Deacon, Becky Gibson, SPHR, CPTD, Nick Ruffin, PMP, Anthony L., Ryan Norton, CFM, FMP, William Hinton, Travis Goodsell, Alec Sheehy, Josh Seeger, Nadja Hunter, MBA #Culture?
-
-
Today, on #ScienceAppreciationDay, we celebrate the curiosity, innovation, and dedication that drive scientific discovery forward. At #AskBio, we’re especially grateful for our incredible researchers who work to advance life-changing therapeutics and bring hope to patients around the world. On this day in 1953, Dr. Jonas Salk announced the successful development of the polio vaccine—an achievement that saved lives and changed the course of medicine. His legacy reminds us of the transformative power of science, and we’re proud to carry that spirit forward every day. Here’s to the scientists—past, present, and future—who continue to shape a healthier tomorrow.
-
Learn more about the past, present, and future of gene therapy in #HeartFailure. Mark your calendar and join us for lunch and an engaging Industry Expert Theater session at #ACC25 in the Expo Hall, Theater 1, Expo 16077! Gain fresh insights into #CardiovascularHealth from speakers Roger Hajjar, MD;?Tim Henry, MD, FACC, MSCAI; JoAnn Lindenfeld, MD, FHSA; and Javed Butler, MD. Explore expert perspectives on AAV gene therapy, featuring updates from the GenePHIT Phase 2 trial of AB-1002. Check out the agenda for ACC.25! ?? https://bit.ly/41masXp #GeneTherapy #CHF #ClinicalTrials
-
Our Talent Acquisition team has been busy connecting with passionate students and future innovators at career fairs across Duke University, University of North Carolina at Chapel Hill, North Carolina State University, North Carolina Central University, and University of Pennsylvania. We’re inspired by the next generation of talent and proud to share the mission of #AskBio with those who are eager to shape the future of genetic medicine. Thank you to all the students we met. We enjoyed speaking with you and appreciate your stopping by, asking thoughtful questions, and exploring where your careers could take you with AskBio. For those we haven’t yet met, if you’re driven to push at the boundaries of what’s possible, bring transformative therapeutics to patients in need, and grow in an environment that’s conducive to reaching your full potential, explore our open opportunities: https://lnkd.in/gkpPZ6at #CareerFairs #BiotechCareers #GeneTherapy Amanda Carson, William Hinton, KaCie Willis, Asia J. Y., James Aykit, Amanda Peterson, Blake Rust, Deanna Sedlak, Kayla Shumate, PhD, Joe Fulbright, Blanca López de Juan Abad, Liang Zhou, D'Shawna Burwell
-
This #MSAAwarenessMonth, our hearts are with the patients, families, and caregivers affected by this rare and devastating disease. ?? At #AskBio, we’re helping shine a light on the powerful work of Mission MSA and DEFEAT MSA ALLIANCE (USA)—organizations offering hope and support to caregivers, healthcare professionals, and those living with MSA. To learn more about MSA and what we can all do to stand in solidarity with the MSA community, please visit the websites of these two amazing organizations: ?? https://missionmsa.org/ ?? https://defeatmsa.org/
-
Saturday marked International Women's Day, a powerful reminder of the incredible contributions of women worldwide. As we carry that spirit forward, we're thrilled to share that tomorrow our Women's Leadership Initiative (WLI) Employee Resource Group (ERG) is hosting a fireside chat on gender equity in the workplace. This event is especially meaningful for us, because women make up over 50% of the #AskBio team and are essential in our effort to drive scientific breakthroughs. Whether they are pioneering research in gene therapy, leading our clinical trials, or serving on our Board, women at AskBio are making a tangible difference in all we do to hopefully improve the lives of patients living with some of the world’s most devastating diseases. Let's continue to celebrate and empower women in science and leadership! #InternationalWomensDay #WLI #WomenInScience #GeneTherapy Albana Alili Dalipi, Stacy W., Deb Cole, Waldy San Sebastian, Claire My Dung TRAN, Meg Heim, Tracy Dowling
-
Limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) is a rare disease and there is currently no treatment that modifies disease progression. #AskBio is dedicated to harnessing the potential of gene therapy to provide improved treatment options for LGMD2I/R9 worldwide. A critical component of this work is the advancement of our Phase 1/2 LION-CS101 clinical trial in the US, which is currently enrolling.? ? For Medical Media – Read our press release here:?https://lnkd.in/efQVDqYK ? #GeneTherapy #LGMD #RareDisease? Blair Robertson, John Jameson, Kenneth Miller, Sam Hopkins, Steven Elmes
-
-
February was a month of dual celebrations at #AskBio! We embraced the opportunity to champion Black history and heart health with a variety of events. Our celebrations included a Black History Month kick-off and trivia game, organized by our African American Employee Resource Group (AA ERG), along with the “Day in the Life of an AA ERG Member” panel discussion; insightful discussions with Bayer on clinical trial diversity; and a virtual conversation on diversity, equity, and inclusion. We also promoted heart health awareness with initiatives like National Wear Red Day; benefitted from hands-free CPR training led by the American Heart Association; and provided healthy snack options for our teams in North Carolina, Philadelphia, Ohio, Heidelberg (Germany), Paris (France), and Edinburgh (Scotland). An AA ERG-sponsored cupcake celebration provided a sweet ending to a month packed with learning. We're proud of our employee-organized activities and remain dedicated to fostering a culture where every voice is heard and valued, and where employee health and well-being are prioritized. ?#BlackHistoryMonth #HeartMonth #GeneTherapy? ? Julius C. Graham, Doug Schantz, Melissa Murrell, William Hinton, Caitlin Taroski, Asia J. Y., Dylo Lisa Ratliff, MCPC, Gaelle M., Kevin Webster, Amanda Carson, Delicia Bryant, Blanca López de Juan Abad, Dexter Emery, Kavonne Brooks, Irene G., Youjun Chen, Larissa Benavente, Ronna Dornsife, M.S.; Blake Rust, Cassandra Simone, Nadja Hunter, MBA; Shari Gordon, Kim Clarke, Meg Heim, Eisha S. C., Jenny Siferd, SPHR, Emily Slocumb, Horace Rozier, Ellen Kelly, Heather Caro, CA-AM, Pooja Merchant, Kara Witcoff, Santosh Sanganalmath MD, PhD, FACC; Ilaria Montalbano, Farah CHALI, Lesley Flood, Rosheen Caw, Stacey L. Abby, Pharm.D., Mary Shaffer
-
Happy to have the opportunity to sponsor this important event being organized by The Speak Foundation and CureLGMD2i Foundation.? #LGMD2I/R9 #GeneTherapy?
The Speak Foundation and Cure LGMD 2i personally invite you to an exclusive and enlightening webinar on March 26th at 3pm ET featuring Dr. Nicholas Johnson with Virginia Commonwealth University. We will explore the potential of gene therapy in treating Limb-Girdle Muscular Dystrophy (LGMD 2I/R9). Register today at https://lnkd.in/ggGnGGgG. During this engaging session, Dr. Johnson will share insights into AskBio's ongoing LGMD2I/R9 clinical study (LION-CS101) and discuss the potential impact of gene therapy treatment now and in the future. Don't miss this unique opportunity to deepen your understanding of the science behind gene therapy and hear directly from a leading expert at the forefront of innovative treatments. Q and A will also follow the webinar with Kelly Brazzo from Cure LGMD 2i hosting along with Kat Bryant Knudson from the Speak Foundation. #LGMD #clinicaltrials #LGMD2i #Genetherapy
-